As a Trustee and the Chief Medical Advisor to The Hypermobility Syndromes Association (HMSA), Dr Hakim is dedicated to supporting the charity and its membership of patients, carers, families and allied professional colleagues working in this field of Medicine. Click here for the HMSA
Dr Hakim is also a Medical Advisor to Ehlers-Danlos Support, UK. Click here for EDS UK
The international charity, The Ehlers-Danlos Society was launched in May 2016. Dr Hakim is a member of the Medical and Scientific Board, and a member of the Steering Committee of the International Consortium that supports the charity.
For the last 4 years Dr Hakim has also co-produced, chaired, and is a faculty teacher on the Pfizer iQ Leaders and Leaders Advance Programmes. The courses run approximately twice a year for clinicians and therapists in leadership roles in Musculoskeletal Medicine. The programme is always very well received but in November 2016 achieved an unprecedented 100% for ‘Excellence’ and “Recommendation to a Colleague” in its delegate feedback.
Dr Hakim was from Oct ’12 to Dec ’17 a Board member to each of the 5 CCGs that constitute CWHHE Clinical Commissioning Group Collaborative in the boroughs of Westminster (Central London CCG), Kensington & Chelsea (West London CCG), Hammersmith & Fulham, Hounslow, and Ealing. He has been Chair of the System Resilience Groups for inner North West London, Vice Chair of their collaborative Quality and Performance committee, and is a member of their Investment, Remuneration, Co-commissioning, and Audit committees.
To read more about each of the CCGs in CWHHE Clinical Commissioning Group Collaborative click on relevant link below: